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1. Introduction
   Over 450 million people are infected each year due 
to complications of parasitic diseases. Indicators show 
that parasitic diseases cause annual mortality of more 
than 200 thousand people. Currently many drugs used to 
treat parasitic diseases are expensive, toxic, with side 
effects and drug resistance. However, medicinal plants 
and herbs having effective bioactive metabolites with 
pharmacological effects can well represent natural source 
of cheap drugs and are less harmful. In this review article, 
the most common and most effective herbal medicines on 
pathogenic protozoa Sarcomastigophora branches such 
as Trypanosoma, Leishmania, Amoeba, Trichomonas 
and Giardia were reviewed. Protozoa Sarcomastigophora 
branch is divided into two subcategories: Sarcodina and 
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Mastigophora. Sarcodina (amoeba) comprise a large group 
of protozoa, most of their lives are free-living; some are 
parasitic and some are both parasitic and free-living. 
Some amoeba can be pathogenic to man, and some live 
as a commensal in humans and are harmless to humans. 
Several species of amoeba have been identified as human 
parasites such as Entamoeba histolytica (E. histolytica), 
Entamoeba dispar, Entamoeba moshkovskii, Entamoeba 
hartmany, Entamoeba coli, Entamoeba gingivalis, 
Endolimax nana and Iodamoeba butschli. Flagellates 
are protozoa which are classified under the category of 
Mastigophora. Some flagellates are free-living and some 
are parasitic in vertebrates and invertebrates and may 
impose severe complications. Almost all vertebrates serve 
as hosts of intestinal flagellates. The parasitic flagellates 
in blood and tissue of humans and other mammals can 
belong to Trypanosomatida and genus of Leishmania 
and Trypanosoma[1]. According to the World Health 
Organization (WHO), 3.5 billion people are anually infected 
with parasites, from them 450 million ones get severe 
mobidity[2]. More than 200 thousand deaths annually due 
to parasitic infection have been reported[3]. In this review, 
we tried to introduce the common herbal medicines and 
chemicals affecting pathogenic protozoa category including 
Sarcomastigophora, Trypanosoma, Leishmania, Amoeba, 
Trichomonas and Giardia.
2. Anti-sarcomastigophora branches (Trypanosoma, 
Leishmania, Amoeba, Trichomonas and Giardia)
2.1. Leishmania and leishmaniasis
   Leishmania is a genus of trypanosomatid protozoa and is 
the parasite responsible for the disease leishmaniasis. It is 
spread through sandflies of the genus Phlebotomus in the 
old world, and of the genus Lutzomyia in the new world. At 
least 93 sandfly species are proven or probable Leishmania 
vectors worldwide. Their primary hosts are vertebrates; 
Leishmania commonly infects hyraxes, canids, rodents, 
and humans. Leishmaniasis or leishmaniosis is a disease 
caused by protozoan parasites of the genus Leishmania 
and spread by the bite of certain types of sandflies. The 
disease can present in three main ways as: cutaneous 
leishmaniasis, mucocutaneous leishmaniasis and visceral 
leishmaniasis[1]. WHO has listed leishmaniasis in rows of 
six major parasitic diseases in tropical areas of the world. 
These diseases, including zoonotic disease are endemic 
in 88 countries and exist in four continents. After malaria 
leishmaniasis is considered as the most important tropical 
disease. About 12 million people are currently infected in 
some 98 countries. It is estimated that 350 million people 
live in areas with the risk of disease. It has been shown that 
60 patients die from 500 cases of visceral leishmaniasis. 
More than 90% cases of visceral leishmaniasis are in 
Bangladesh, Brazil, India, Nepal, Sudan and more than 90% 
of cutaneous leishmaniasis are in Iran, Nepal, Syria, Saudi 
Arabia, Afghanistan and Peru[2]. Cutaneous leishmaniasis 
is one of the most common diseases among humans and 
animals in many parts of the world that is caused by 
several species of Leishmania and is considered as a 
public health problem in more than 88 countries[3].
   Visceral leishmaniasis, also known as kala-azar, 
black fever and dumdum fever, is the most severe form 
of leishmaniasis. Leishmaniasis is the second-largest 
parasitic killer in the world (after malaria), responsible 
for an estimated 500 000 infections each year worldwide. 
The parasite migrates to the internal organs such as liver, 
spleen (hence ‘visceral’), and bone marrow, and, if left 
untreated, will always result in the death of the host. Signs 
and symptoms include fever, weight loss, mucosal ulcers, 
fatigue, anemia, and substantial swelling of the liver and 
spleen. Of particular concern, according to the WHO, is 
the emerging problem of HIV/visceral leishmaniasis co-
infection[4].
2.2. Chemical and herbal anti-leishmaniasis drugs
   The traditional treatment of leishmaniasis is with 
pentavalent antimonials such as sodium stibogluconate 
and meglumine antimoniate. Resistance is now common 
in India, and rates of resistance have been shown 
to be as high as 60% in parts of Bihar, India. These 
medications are antimonates but, long-term injections 
to 28 d for the variable efficacy against visceral 
leishmaniasis, skin appearance, and resistance against 
it, limit their consumption. Other medications used to 
treat leishmaniasis include pentamidine, miltefosine, 
amphotericin B and so on. Amphotericin B is a pollin 
antibiotic for the treatment of antibiotic resistance. 
This drug has a good effect on Leishmania donovani (L. 
donovani) (visceral leishmaniasis), but the limitations 
are its toxicity and other restrictions that require slow 
intravenous infusion over four hours. Use of pentamidine 
is common because its toxicity is low. The most important 
achievement of effective oral treatment for visceral 
leishmaniasis is treatment with miltefosine which is 
chemically a derivative of alkylphosphocholine compounds 
that originally developed as an anticancer drug in the late 
1980s[5]. After reveal of its antileishmaniasis effect, the 
drug became the first (and still the only prescribed) oral 
drug in the treatment of leishmaniasis[6]. The mechanism 
of treatment of leishmaniasis with miltefosine is that the 
drug impairs metabolism of alkyl-linked phospholipid 
and glycolipid and glycoprotein biosynthesis[7]. Studies 
have shown that miltefosine cause cell death in all forms 
of leishmaniasis. Baradaran et al. suggested against L. 
donovani by treatment with a combination of several 
techniques that include propidium iodide staining and 
DNA fragmentation assay[8]. In another study, Amini et al. 
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studied the effect of miltefosine on L. donovani (LD-As20) 
which became arsenate-resistant promastigotes[9]. Their 
studies have shown that miltefosine induces programmed 
cell death in LD-As20 in a time-dependent manner by cell 
shrinkage; serine and phosphatidylcholine data transfer is 
determined by DNA fragmentation. Miltefosine treatment 
leads to loss of mitochondrial membrane potential and 
release of cytochrome C with subsequent activation of 
cellular proteases. So this study showed the death of L. 
donovani, resistant to arsenate, by miltefosine. Because 
in recent years miltefosine is used in clinical trials as 
an anti-Leishmania therapy, to better understand the 
mechanisms regulating cell death for the design of new 
therapeutic strategies against Leishmania. Today, several 
factors such as drug toxicity, method of administration, 
cost of drug and drug resistance in Leishmania spp. have 
caused some limitations to treat leishmaniasis. Hence, the 
preparation of new effective drugs with low side effects and 
toxicity, and affordable price is needed. The traditional 
medicinal plants have been shown to be effective and 
inexpensive, and are currently used for the treatment of 
various infectious diseases such as viral[10], bacterial and 
parasitic infections complications[11-14], as well as non-
infectious diseases such as cancer[15,16], diabetes[6,17], 
atherosclerosis[18,19], cardiovascular and Alzheimer 
deseases and complications[20-23]. In comparison to 
synthetic drugs, the herbal medicines usually have less 
toxic or side effects[24,25]. 
   Nasri and his colleagues focused on natural products 
with activity against Leishmania[26]. Compounds isolated 
from plants and microorganisms have suitable chemical 
groups such as alkaloids, flavonoids, terpenes, steroids, 
lactones, quinine and lignans which have positive effects 
on the parasites. More recent studies have emphasized on 
the evaluation of medicinal plants used for the discovery of 
safe and effective drugs[25].
2.3. Amoeba and amoebiasis
   Amoebiasis or amebiasis, refer to infection caused 
by the amoeba E. histolytica. Invasion of the intestinal 
lining causes amoebic dysentery or amoebic colitis[24]. 
It is estimated that about 50 million infected with E. 
histolytica and around 40 000 to 100 000 deaths occur 
annually worldwide, so it is considered as one of the most 
important human pathogenic protozoa[27-29]. Amoebiasis 
can cause more than 100 thousand deaths per year, which 
is regarded as a fatal parasitic disease after malaria and 
schistosomasis[30]. The amoeba infection is asymptomatic 
in 80% of cases[31]. Infants who are not breastfeed, pregnant 
women, children with poor nutrition, nursing and mental 
retardation as well as people with immunodeficiency 
conditions are high risk groups of amoeba E. histolytica 
infection[32]. E. histolytica invades the colon, but in some 
cases beyond the intestine and the liver, lung and brain 
which can show signs of severe and fatal condition[33,34].
2.4. Chemical and herbal anti-amoebiasis drugs
   Development of anti-amoebiasis new drugs and vaccines 
is still in its early stages and the dream seems far away. 
Future development of resistance to drugs may seriously 
affect the amoebiasis control[35,36]. Metronidazole the drug 
of choice and other compounds derived from nitroimidazole 
like tinidazole, secnidazole and ornidazole are equally 
effective. Diloxanide furoate, diiodohydroxyquinoline, 
paromomycin, emetine and chloroquine as well as 
alternative medicines are used. Metronidazole, tinidazole 
and other 5-Nitromidazole that kill the trophozoite 
with changes in organelles of amoeba protoplasm, are 
ineffective in treating the cyst. Plant-antiparasitic 
possessing chloroalkyl may act by inhibiting DNA synthesis. 
Dehydroemetine, emetine and metronidazole affect on 
amoeba in intestinal lumen wall but not in the intestinal 
lumen.
   Diloxanide furoate, iodoquinol and paromomycin affect 
on amoeba in the intestinal lumen. Tetracycline inhibits 
bacterial growth in the intestinal wall and lumen. Effect 
of metronidazole on the intestinal wall and the lumen of 
the affected individual has a 50% failure rate because it 
needs to strengthen its action to a luminal amebiasis[37,38]. 
Prevention is essential and includes hand washing, proper 
food handling and boiling water which are questionable 
to 55 °C. Investigations on the effects of various plants in 
Africa have shown that ingestion of fresh papaya seeds can 
help prevent amoebiasis. Two tablespoons of fresh papaya 
seeds twice a week may help reduce the incidence[39-42]. 
Review of plant species assessed in vitro for antibacterial 
activity against Plasmodium or amoebiasis has also been 
published[9]. Chemically control of worms with advanced 
management is an important control strategy around 
the world. Increased resistance to the drug is a serious 
problem leading to the search for medicinal plants with 
antimicrobial activity[43]. Several herbs from traditional 
medicines are used as alternative for control of intestinal 
worms. Some common plants are used by different cultures 
for the control and elimination of intestinal worms include: 
castor, black walnut, wormwood, Artemisia vulgaris, cloves, 
chamomile and herbal black seed, and Dryopteris filix-
mas L. Although these plants have anthelmintic effects, 
they should not be used without correct dosage for humans, 
because they are toxic and dangerous[24].
2.5. Trypanosoma and trypanosomiasis
   Trypanosoma is a genus of kinetoplastids and class 
Kinetoplastida which is a monophyletic group of unicellular 
parasitic flagellate protozoa. The name is derived from 
the Greek trypano (borer) and soma (body) because of 
their corkscrew-like motion. All trypanosomes are 
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heteroxenous requiring more than one obligatory host 
to complete life cycle and most are transmitted via a 
vector. The majority of species are transmitted by blood-
feeding invertebrates, but there are different mechanisms 
among the varying species. In an invertebrate host they 
are generally found in the intestine, but normally occupy 
the bloodstream or an intracellular environment in the 
mammalian host. Trypanosomes infect a variety of hosts 
and cause various diseases, including the fatal human 
diseases, sleeping sickness, caused by Trypanosoma brucei, 
and Chagas disease, caused by Trypanosoma cruzi. The 
mitochondrial genome of the Trypanosoma, as well as of 
other kinetoplastids known as the kinetoplast, is made up of 
a highly complex series of catenated circles and minicircles 
and requires a cohort of proteins for organisation during 
cell division[44,45].
2.6. Chemical and herbal anti trypanosomiasis drugs
   The drugs currently used to treat sleep sickness, include 
suramin, pentamidine, melarsoprol, eflornithine, and 
nifurtimox[46]. Suramin was introduced in the early 1920s 
as the drug of choice for treating early phase of infection 
with Trypanosoma brucei rhodesiense[47]. A drug from Bayer 
in 1916 by Oscar Drsl and Richard Cote was created[48], 
which was under investigation for the treatment of prostate 
cancer. Suramin is used for the treatment of human African 
trypanosomasis in first stage of infection when parasites 
are largely found in the blood, but when the parasites 
invade the central nervous system it is ineffective due to 
the inability of suramin in crossing the blood-brain barrier 
and blood-cerebrospinal fluid barrier to achieve adequate 
levels of concentration in the tissue target[49]. However, 
there is evidence that suramin can reach certain parts of 
the central nervous system. So that the cerebral cortex of 
mice infected with Trypanosoma brucei rhodesiense was 
successfully treated[12].
   By receptor-mediated endocytosis, suramin is thought 
to be an anti-parasite drug which acts slowly, possibly 
because low density lipoprotein endocytosis of host is 
connected. In addition, El Al Di receptors are expressed 
at the blood brain barrier and it is believed to be involved 
in the transit of low density lipoprotein to the brain[49]. 
Suramin co-administration with drugs that are active 
against the parasite in the central nervous system, such 
as melarsoprol, eflornithine and nifurtimox show signs of 
improvement in the rate of treatment[49].
   Pentamidine was first introduced in 1949. This medication 
is only used as a second-degree drug and its usage is 
contraindicated during the treatment with suramin[47]. 
Melarsoprol was introduced in 1949 for the treatment 
of sleep disorders in its last stages, but caused serious 
side effects such as reactive encephalopathy in 5% to 
10% of cases. It also causes vomiting, abdominal pain 
and peripheral neuropathy. Melarsoprol can reduce 
trypanothione reductase and inhibit trypanothione level[50]. 
Eflornithine is drug of choice for the treatment of late stage of 
sleeping sickness caused by Trypanosoma brucei gambiense 
but it is not recommended against Trypanosoma brucei 
rhodesiense. It inhibits the biosynthesis of polyamines by 
eflornithine; range of downstream biochemical effects that 
would cause trypanocidal activity was affected[51]. 
   Nifurtimox has been recorded as another drug to treat 
sleeping sickness. Nifurtimox often has side effects, and 
only 50% of patients are able to complete a full course of 
their treatment, but the treatment of late stage of sleeping 
sickness in which eflornithine and melarsoprol are used 
is usually ineffective[52]. Drugs used to treat Americans 
sleep disorders are nifurtimox and benzimidazole[53]. 
Because many drugs now available to treat African sleeping 
sickness are toxic, researchers around the world try to 
discover new molecules which are safe and cost-effective 
from the medicinal herbs. Until mid 1995, Spoloda-Bouza 
and Cassels examined plant metabolites active against 
Trypanosoma cruzi[54]. Fournet et al. in 1994, collected 
43 plants from Bolivia with trypanocidal activities[55]. In 
another study, Rojas de Arias et al. studied the plants 
with moderate to high activity in vitro and in vivo against 
Trypanosomya species (sleeping sickness)[56].
2.7. Giardia and giardiasis
   Giardiasis (popularly known as beaver fever) is a zoonotic 
parasitic disease caused by the flagellate protozoan Giardia 
lamblia (also sometimes called Giardia intestinalis and 
Giardia duodenalis). The Giardia organism inhabits the 
digestive tract of a wide variety of domestic and wild animal 
species, as well as humans and and compete with the host 
in food absorbtion[57-61]. Infection with this parasite has 
been reported in all parts of the world and the infection rate 
is 1% to 25%[62]. It is the most common pathogenic parasitic 
infection in humans worldwide. In 2013, there were about 
280 million people worldwide with symptomatic giardiasis.
2.8. Chemical and herbal anti-giardiasis drugs
   Treatment is not always necessary as the infection usually 
resolves on its own. However, if the illness is acute or 
symptoms persist and medications are needed to treat it, 
medications such as metronidazole, tinidazole, secnidazole 
or ornidazole are used[63]. The mechanism of killing of 
Giardia by metronidazole has been studied more fully. 
Metronidazole has an anaerobic metabolic pathways in 
Giardia[63]. The drug enters the trophozoite and destruct 
its growth[22]. The drug is activated by reducing the nitro 
group[64]. Slope agrees with the intracellular transport of 
metronidazole and is spread by the reduction reaction. 
Metronidazole reduction as a terminal electron acceptor 
binds covalently to DNA macromolecules[65]. This leads to 
DNA damage, the loss of helical structure, impaired template 
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function and strand breakage and subsequent death of 
trophozoite appears. In addition to this work, metronidazole 
inhibits the respiration of trophozoite[15].
   Metronidazole reduction activities may also lead to toxic 
radicals that react with cellular components[22]. Within the 
cyst and trophozoite, nitroimidazole may be less affected, 
probably due to poor penetration of the drug through the 
cyst wall[66]. Resistance to metronidazole was tested in vitro. 
The activity of parasite pyruvate reduction is related to 
the reduction of nitroimidazole ferredoxin; oxidoreductase 
is required for activity[67]. Metronidazole is rapidly and 
completely absorbed after oral administration and penetrates 
the body’s tissues and saliva, breast milk, semen and 
vaginal secretions seep. The drug is metabolized primarily 
in the liver and is excreted through the urine[68]. In 1980, a 
laboratory experiment was conducted to determine the drug 
sensitivity of the nitroimidazole. In 1980 by microscopic 
evaluation of morphology and motility of Giardia lamblia, it 
was shown that metronidazole and tinidazole are effective[69]. 
Subsequently, the morphology, growth inhibition, thymidine 
incorporation, lethal concentration, vital dye exclusion, 
inhibition of adherence, drug metabolism and response 
assessment to measure the effect of many therapeutic 
agents in vitro were evaluated[70]. However, as many studies 
have shown, there is no standard laboratory conditions to 
compare the results and laboratory findings with clinical 
situations. The nitromidazole, tinidazole and metronidazole 
consistently have been shown to possess the best activity 
in vitro[71-73]. This disease is treated well with nutritional 
and herbal therapy intervention. The intervention is done 
by adding a probiotic cotaining Lactobacillus such as 
fructooligosaccharides, dietary fiber, wheat germ, etc. 
Reduced dairy products containing lactose may help to 
control giardiasis. Herbs that can help to control giardiasis 
include garlic and pepper[74]. Pippali rasayana Ayurveda 
product, may also help in controlling giardiasis. Some 
flavonoids and tannins found in plants like marjoram, 
psidium guajava, mangifera indica and plantain are used to 
control diarrhea.
2.9. Trichomonas or trichomoniasis
   Trichomonas vaginalis (T. vaginalis) is a protozoan 
flagella found in the human genitourinary system that will 
be replaced by the protozoan trophozoite forms and just 
multiply by longitudinal binary division[75]. The protozoan 
is transmitted through sexual contact, so that in all cases, 
it is the most common sexually transmitted disease in the 
world. T. vaginalis cause nearly 180 million new infections 
each year. This parasite is one of the most common causes 
of non-viral sexually transmitted disease[76-78]. At least six 
million women and their partners each year in the United 
States are infected with T. vaginalis for sexually transmitted 
diseases. Vaginitis and cervicitis in women and urethritis in 
both sexes may be caused by this parasite. These parasites 
can cause prostatitis in men as well. The incubation period 
of the disease is 4 to 28 d. Vulva and vagina itchy and vaginal 
discharge are usually acute and happen during menstruation 
or shortly after it[79-81]. As stated, in 90% of wemen infected 
with the protozoa in the cervical region, damage is caused by 
infection with a virus that can cause cancer[82-84].
2.10. Chemical and herbal anti-trichomoniasis
   The effect of standard chemotherapy consisting of 
5-nitroimidazole like that of metronidazole and tinidazole. 
Because some strains are resistant to drugs of Trichomonas, 
new drugs are needed. Natural products like alternative 
alkaloids (berberine), dibenzofuran, anthraquinones and 
polyacetylenes, saponins and diterpenoid have been 
tested[85]. Nowadays, experimental researches on parasitic 
diseases have increased, which are necessary because 
parasitic diseases and treatment with natural remedies are 
very important[86-96].
   In this study, we tried to collect information about 
herbal remedies affecting normal and pathogenic protozoa 
category Sarcomastigophora and these information can be 
recommended because of the ideal natural resources for the 
clinical research work on other parasitic diseases. 
3. Discussion and conclusion
   In this review study, we identified and presented 
valuable source of medicinal herbs which are used as 
natural medicinal products for prevention and treatment 
of pathogenic protozoan Sarcomastigophora branches 
(Trypanosoma, Leishmania, Amoeba, Trichomonas and 
Giardia). These herbs usually have various effects and 
are used for different diseases in addition to parasitic 
infections. The mechanism actions of these plants against 
the complications of these deseases are not clear and 
should be established. Most of plants properties have been 
attributed to their antioxidant activities[6,9,74,85,97,98], which is 
mostly due to the presence of phenolic components[22,40,42]. 
These phenolic compounds usually have antimicrobial 
activity[90,93]; however, other components of the plants should 
be involved in the activities of these plants, too.
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